Julie Saba, MD PhD named 2022 UCSF Catalyst Awardee

Congrats to Dr. Julie Saba on her award for "Adeno-associated Virus-mediated SGPL1 Gene Therapy".  Check out the list of other 2022 Catalyst Awardees

"The Catalyst Program is UCSF’s translational accelerator focused on advancing UCSF discoveries with clinical impact and commercial potential. The Catalyst Program aims to foster academic and industry collaborations as well as enhance education in early translational research and entrepreneurship."

"The centerpiece of the Catalyst Program is the Catalyst Awards, our program that provides both industry advisor mentorship and seed funding to UCSF Principal Investigators with promising projects. The Catalyst Awards are focused on the development of therapeutics, diagnostics, medical devices, digital health, and biotools."